These findings collectively reveal that KLF9 suppresses HCC risk factors by maintaining redox homeostasis and inhibiting inflammatory pathways, suggesting a broader tumor-suppressive function in cancers linked to metabolic dysfunction (29). The gene discussed is KLF9; the disease is neoplasm.